Jim Simons
CELU icon

Jim Simons’s Celularity CELU Stock Holding History

Jim Simons’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,000
Closed -$86.9K – 3285
2025
Q3 		$86.9K Buy
42,000
+29,800
+244% +$83.4K ﹤0.01% 3274
2025
Q2 		$23.9K Buy
+12,200
New +$22.2K ﹤0.01% 3458
2025
Q1 		– Sell
-11,000
Closed -$22.9K – 3502
2024
Q4 		$22.9K Sell
11,000
-12,380
-53% -$29.5K ﹤0.01% 3476
2024
Q3 		$69.4K Sell
23,380
-2,118
-8% -$6.24K ﹤0.01% 3311
2024
Q2 		$79.8K Sell
25,498
-4,270
-14% -$14.8K ﹤0.01% 3224
2024
Q1 		$156K Sell
29,768
-54,579
-65% -$224K ﹤0.01% 3281
2023
Q4 		$209K Buy
84,347
+30,007
+55% +$65.2K ﹤0.01% 3119
2023
Q3 		$121K Buy
54,340
+26,899
+98% +$96.6K ﹤0.01% 3207
2023
Q2 		$146K Buy
27,441
+19,421
+242% +$124K ﹤0.01% 3371
2023
Q1 		$50K Buy
8,020
+5,640
+237% +$45.4K ﹤0.01% 3665
2022
Q4 		$31K Buy
+2,380
New +$43.9K ﹤0.01% 3882

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $9.42B AUM 17.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Jim Simons's CELU Position: Q4 2025 in Review

Jim Simons sold out of Celularity (CELU) in Q4 2025, closing a stake of 42,000 shares — an estimated $86.9K sold.

Jim Simons first reported a position in CELU in Q4 2022 and held it in 11 quarters. The position peaked at $209K in Q4 2023. 36 funds tracked by Wall St. Rank hold CELU as of Q4 2025.

  • Jim Simons reported no remaining Celularity position as of Q4 2025 after selling out during the quarter.
  • Jim Simons sold 42,000 Celularity shares in Q4 2025, an estimated $86.9K.
  • Jim Simons first reported a position in Celularity in Q4 2022 and held it in 11 quarters.
  • Jim Simons's Celularity position peaked at $209K in Q4 2023.
  • 36 funds tracked by Wall St. Rank held Celularity as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.